An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

NCT04950114 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Kidney Diseases
Glomerulosclerosis
Focal Segmental Nephrosis
Lipoid Urologic Disease
Glomerulonephritis
Nephritis
Nephrosis

Interventions

DRUG: GFB-887

Sponsor

Goldfinch Bio, Inc.